MedPath

The application of nuclear imaging for detection and characterization of primary prostate cancer in patients with 99mTc-HYNIC-Bombesin(7-14) SPECT/CT

Completed
Conditions
prostate cancer
10038588
Registration Number
NL-OMON35521
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Histologically proven prostate cancer
- Patients selected for a radical prostatectomy (part of normal treatment)
- Willingness to cooperate in the study; written informed consent given
- >60 years of age

Exclusion Criteria

- Any signs of neurological or psychiatric disorders that will preclude the patient from expressing its own free will
- Any signs of disease that will prevent the patient from lying in the same position for an hour.
- Other medical research in which patients have been submitted to radiation during the last year
- serum kreatinine >110 umol/l
- Any signs or prior history of other malignancy in pelvis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath